MORGAN LAMBRECHT: Open Payments
NPI 1659088458 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 11 payments from 8 companies in 2025. Trend: 2023 $308 · 2024 $280 · 2025 $2,038
Consulting: $1,263Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $1,418 |
| Astellas Pharma Global Development | 2 | $131 |
| Exelixis Inc. | 1 | $122 |
| Karyopharm Therapeutics Inc. | 1 | $119 |
| Pharmacosmos Therapeutics Inc. | 1 | $117 |
| E.R. Squibb & Sons, L.L.C. | 1 | $85 |
| Iovance Biotherapeutics, Inc. | 1 | $27 |
| Tempus AI, Inc | 1 | $20 |
Products named: ERLEADA, RYBREVANT, Padcev, CABOMETYX, XPOVIO, COSELA, OPDIVO, Amtagvi.
Industry payments across TN — which companies pay providers there.
